ArticleOncology letters2026

Pan-immune-inflammation value as a prognostic and predictive biomarker in metastatic non-small cell lung cancer treated with nivolumab: A real-world study.

Nedim Turan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.